Efficacy News and Research

RSS

FDA grants marketing authorization for new device to help treat carbon monoxide poisoning

The U.S. Food and Drug Administration today allowed marketing of a new device, ClearMate, intended to be used in an emergency room setting to help treat patients suffering from carbon monoxide poisoning.

14 Mar 2019

Shorter treatment for Chagas disease found to be effective and safer than standard treatment

A two-week treatment course for adult patients with chronic Chagas disease showed, when compared to placebo, similar efficacy and significantly fewer side effects than the standard treatment duration of eight weeks, according to the results of a clinical trial in Bolivia led by the Drugs for Neglected Diseases initiative.

14 Mar 2019

Success for new cholesterol-lowering drug

A new, oral drug that effectively lowers LDL or "bad" cholesterol, looks set for clinical approval.

14 Mar 2019

Antibody-drug conjugate effectively targets surface protein in childhood neuroblastomas

Physician-scientists in the Cancer Center at Children's Hospital of Philadelphia have developed a preclinical, potent therapy attached to an antibody that targets a surface protein expressed in most childhood neuroblastomas, effectively killing cancer cells.

14 Mar 2019

Increased stress hormones accelerate breast cancer metastasis

It has long been thought that stress contributes to cancer progression. Scientists from the University of Basel and the University Hospital of Basel have deciphered the molecular mechanisms linking breast cancer metastasis with increased stress hormones.

14 Mar 2019

Study: Low-risk hip replacement patients can skip standard hip precautions

Low-risk patients undergoing a total hip replacement with a posterior approach can skip the standard hip precautions currently recommended for post-surgical recovery, according to a new study conducted at Hospital for Special Surgery, in New York City.

13 Mar 2019

Rise of MRSA in hospitals linked to common disinfectant

A new study has found a possible link between the use of disinfectants in hospitals and the rise of methicillin-resistant Staphylococcus aureus (MRSA) on patient wards.

13 Mar 2019

“Fail Fast, But More Confidently”: Developing Organoids for Drug Development and Discovery

Richard Eglen discusses the use of organoids in drug discovery, including the screening of candidate compounds for efficacy, toxicity, and pharmacokinetics.

From Corning Life Sciences 13 Mar 2019

Mushroom consumption may reduce odds of having mild cognitive impairment

A team from the Department of Psychological Medicine and Department of Biochemistry at the Yong Loo Lin School of Medicine at the National University of Singapore has found that seniors who consume more than two standard portions of mushrooms weekly may have 50 per cent reduced odds of having mild cognitive impairment.

12 Mar 2019

Mental health of students could be improved by introducing mindfulness training

Mental health amongst university students could be improved by introducing mindfulness training. These are the findings from the first UK study, published in Education Research International, to measure the efficacy of mindfulness-based cognitive therapy on students.

11 Mar 2019

Proving the efficacy of traditional Chinese medicine

Using GC-MS, scientists have uncovered the anti-pyretic mechanisms of Jinxin, a traditional Chinese medicine typically prescribed for fever.

11 Mar 2019

Virginia Tech professor uses mathematical modeling simulations to assess vaccine efficacy

The recent measles outbreaks across the country emphasize the importance of vaccinations.

11 Mar 2019

New machine learning-based approach to predict recovery time of sports-related concussions

The prevalence of concussions in sports is well known. So, too, is the challenge clinicians and others face when they have to decide when an athlete can return to the game after a head injury.

8 Mar 2019

Study suggests two deep brain stimulation sites that are effective for treating OCD

Deep brain stimulation reduces symptoms of severe obsessive-compulsive disorder during stimulation of either the ventral capsule or anteromedial subthalamic nucleus, according to a study in Biological Psychiatry.

8 Mar 2019

Quanterix corporation releases operating results for fourth quarter and full year 2018

Quanterix announced financial results for the three months and twelve months ended Dec. 31, 2018.

From Quanterix 7 Mar 2019

CAR-T cell therapy could be on the horizon for patients with lupus

Researchers have developed a novel CAR-T cell therapy that can reduce B cell numbers known to cause the inflammatory responses in lupus.

7 Mar 2019

Cities and counties unlikely to heed FDA warning on importing foreign drugs

Cities and local governments in several states said they will continue to use a Canadian company to offer employees prescription drugs at a highly reduced price, even though federal officials raised safety concerns about the practice last week.

7 Mar 2019

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

6 Mar 2019

Research offers new hope for seasonal allergy sufferers

One in three people is plagued by an allergy, triggered by foodstuffs, fungi, house dust mites or on a seasonal basis due to pollen. The latter group is the largest: around 800 million people worldwide suffer from some form of allergy to pollen, with the usual symptoms such as a runny nose, cough and severe breathing problems.

6 Mar 2019

Ieso integrates AI into its mental health treatment platform

Today, Ieso Digital Health will integrate Artificial Intelligence into its therapist platform for the first time.

6 Mar 2019

Efficacy News and Research

FDA grants marketing authorization for new device to help treat carbon monoxide poisoning

Shorter treatment for Chagas disease found to be effective and safer than standard treatment

Success for new cholesterol-lowering drug

Antibody-drug conjugate effectively targets surface protein in childhood neuroblastomas

Increased stress hormones accelerate breast cancer metastasis

Study: Low-risk hip replacement patients can skip standard hip precautions

Rise of MRSA in hospitals linked to common disinfectant

“Fail Fast, But More Confidently”: Developing Organoids for Drug Development and Discovery

Mushroom consumption may reduce odds of having mild cognitive impairment

Mental health of students could be improved by introducing mindfulness training

Proving the efficacy of traditional Chinese medicine

Virginia Tech professor uses mathematical modeling simulations to assess vaccine efficacy

New machine learning-based approach to predict recovery time of sports-related concussions

Study suggests two deep brain stimulation sites that are effective for treating OCD

Quanterix corporation releases operating results for fourth quarter and full year 2018

CAR-T cell therapy could be on the horizon for patients with lupus

Cities and counties unlikely to heed FDA warning on importing foreign drugs

Esketamine nasal spray approved for management of treatment-resistant depression

Research offers new hope for seasonal allergy sufferers

Ieso integrates AI into its mental health treatment platform

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News